Cathepsin L is involved in 6-hydroxydopamine induced apoptosis of SH-SY5Y neuroblastoma cells

[1]  Neil D. Rawlings,et al.  MEROPS: the peptidase database , 2009, Nucleic Acids Res..

[2]  Feng Qi Han,et al.  Olomoucine inhibits cathepsin L nuclear translocation, activates autophagy and attenuates toxicity of 6-hydroxydopamine , 2009, Brain Research.

[3]  R. Chang,et al.  Dietary oxyresveratrol prevents parkinsonian mimetic 6-hydroxydopamine neurotoxicity. , 2008, Free radical biology & medicine.

[4]  Feng Qi Han,et al.  Neuronal injury in rat model of permanent focal cerebral ischemia is associated with activation of autophagic and lysosomal pathways , 2008, Autophagy.

[5]  R. Durmaz,et al.  The Protective Effect of Dexanabinol (HU-211) on Nitric Oxide and Cysteine Protease-Mediated Neuronal Death in Focal Cerebral Ischemia , 2008, Neurochemical Research.

[6]  Z. Qin,et al.  An autophagic mechanism is involved in apoptotic death of rat striatal neurons induced by the non-N-methyl-D-aspartate receptor agonist kainic acid , 2008, Autophagy.

[7]  T. Chase,et al.  NF-κB contributes to 6-hydroxydopamine-induced apoptosis of nigral dopaminergic neurons through p53 , 2007, Brain Research.

[8]  Limin Zheng,et al.  Cathepsin‐cleaved Bid promotes apoptosis in human neutrophils via oxidative stress‐induced lysosomal membrane permeabilization , 2007, Journal of leukocyte biology.

[9]  S. Katiyar,et al.  Grape seed proanthocyanidins inhibit UV-radiation-induced oxidative stress and activation of MAPK and NF-kappaB signaling in human epidermal keratinocytes. , 2006, Free radical biology & medicine.

[10]  M. O'Neill,et al.  6-Hydroxydopamine-induced Apoptosis Is Mediated via Extracellular Auto-oxidation and Caspase 3-dependent Activation of Protein Kinase Cδ* , 2006, Journal of Biological Chemistry.

[11]  Z. Qin,et al.  Lysosomal enzyme cathepsin B is involved in kainic acid-induced excitotoxicity in rat striatum , 2006, Brain Research.

[12]  Erwan Bezard,et al.  Protective effect of green tea polyphenols on the SH-SY5Y cells against 6-OHDA induced apoptosis through ROS-NO pathway. , 2005, Free radical biology & medicine.

[13]  L. Greene,et al.  Puma and p53 Play Required Roles in Death Evoked in a Cellular Model of Parkinson Disease , 2005, Neurochemical Research.

[14]  C. Thiele,et al.  Glycogen synthase kinase 3β (GSK3β) mediates 6‐ hydroxydopamine‐induced neuronal death , 2004 .

[15]  A. Schober,et al.  Genes, proteins, and neurotoxins involved in Parkinson’s disease , 2004, Progress in Neurobiology.

[16]  M. Zigmond,et al.  Effects of 6‐hydroxydopamine on primary cultures of substantia nigra: specific damage to dopamine neurons and the impact of glial cell line‐derived neurotrophic factor , 2004, Journal of neurochemistry.

[17]  J. Haddad.  Redox and oxidant-mediated regulation of apoptosis signaling pathways: immuno-pharmaco-redox conception of oxidative siege versus cell death commitment. , 2004, International immunopharmacology.

[18]  J. Jordán,et al.  Bcl‐xL blocks mitochondrial multiple conductance channel activation and inhibits 6‐OHDA‐induced death in SH‐SY5Y cells , 2004, Journal of neurochemistry.

[19]  V. Campbell,et al.  Aβ-mediated activation of the apoptotic cascade in cultured cortical neurones: a role for cathepsin-L , 2004, Neurobiology of Aging.

[20]  Patrik Brundin,et al.  Pathogenesis of parkinson's disease: dopamine, vesicles and α-synuclein , 2002, Nature Reviews Neuroscience.

[21]  M. Mattson,et al.  p53 inhibitors preserve dopamine neurons and motor function in experimental parkinsonism , 2002, Annals of neurology.

[22]  J. Lumpkin,et al.  A novel in vivo post‐translational modification of p53 by PARP‐1 in MPTP‐induced parkinsonism , 2002, Journal of neurochemistry.

[23]  S. Cory,et al.  The Bcl2 family: regulators of the cellular life-or-death switch , 2002, Nature Reviews Cancer.

[24]  E. Melamed,et al.  6-Hydroxydopamine Increases Ubiquitin-Conjugates and Protein Degradation: Implications for the Pathogenesis of Parkinson's Disease , 2001, Cellular and Molecular Neurobiology.

[25]  B. Antonsson.  Bax and other pro-apoptotic Bcl-2 family "killer-proteins" and their victim the mitochondrion , 2001, Cell and Tissue Research.

[26]  K. Kinzler,et al.  PUMA induces the rapid apoptosis of colorectal cancer cells. , 2001, Molecular cell.

[27]  J. Levine,et al.  Surfing the p53 network , 2000, Nature.

[28]  M. Crompton.  Bax, Bid and the permeabilization of the mitochondrial outer membrane in apoptosis. , 2000, Current opinion in cell biology.

[29]  E. Hirsch,et al.  Caspase-3: A vulnerability factor and final effector in apoptotic death of dopaminergic neurons in Parkinson's disease. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[30]  N. Katunuma,et al.  Participation of a cathepsin L-type protease in the activation of caspase-3. , 1999, Cell structure and function.

[31]  A. Porter,et al.  NF-κB/Rel Proteins Are Required for Neuronal Differentiation of SH-SY5Y Neuroblastoma Cells* , 1999, The Journal of Biological Chemistry.

[32]  M. Dragunow,et al.  The toxicity of 6-hydroxydopamine on PC12 and P19 cells. , 1999, Brain research. Molecular brain research.

[33]  T. Chase,et al.  Nuclear Factor κB Nuclear Translocation Upregulates c-Myc and p53 Expression during NMDA Receptor-Mediated Apoptosis in Rat Striatum , 1999, The Journal of Neuroscience.

[34]  N. Rothwell,et al.  Caspases Mediate 6‐Hydroxydopamine‐Induced Apoptosis but Not Necrosis in PC12 Cells , 1998, Journal of neurochemistry.

[35]  Dean P. Jones,et al.  Prevention of Apoptosis by Bcl-2: Release of Cytochrome c from Mitochondria Blocked , 1997, Science.

[36]  C. Waters,et al.  Induction of apoptosis in catecholaminergic PC12 cells by L-DOPA. Implications for the treatment of Parkinson's disease. , 1995, The Journal of clinical investigation.

[37]  M. Takeda,et al.  Abnormal distribution of cathepsins in the brain of patients with Alzheimer's disease , 1991, Neuroscience Letters.

[38]  C. Haass,et al.  Mitochondrial dysfunction in Parkinson's disease. , 2010, Biochimica et biophysica acta.

[39]  A. Mclean,et al.  Age-Environment and Gene-Environment Interactions in the Pathogenesis of Parkinson's Disease , 2002, Reviews on environmental health.

[40]  C. Kaltschmidt,et al.  Stimulus-dependent activation of NF-κB specifies apoptosis or neuroprotection in cerebellar granule cells , 2002, NeuroMolecular Medicine.

[41]  A. Baldwin.  Series Introduction: The transcription factor NF-κB and human disease , 2001 .

[42]  J. Haddad,et al.  Glutathione depletion is associated with augmenting a proinflammatory signal: evidence for an antioxidant/pro-oxidant mechanism regulating cytokines in the alveolar epithelium. , 2000, Cytokines, cellular & molecular therapy.

[43]  T. Chase,et al.  Nuclear Factor-κB Contributes to Excitotoxin-Induced Apoptosis in Rat Striatum , 1998 .